Integrated traditional Chinese and conventional medicine in the treatment of anemia due to lower-risk myelodysplastic syndrome: study protocol for a randomized placebo-controlled trial
Qin Zheng(Shanghai University of Traditional Chinese Medicine), Meihong Luo, Yiling Jiang, Manqin Sun(Shanghai University of Traditional Chinese Medicine), Haitao Xu(Shanghai University of Traditional Chinese Medicine), Zhihao Wu(Stanford University), Zeying Yan(Shanghai Jiao Tong University), Jiahui Lü(Wuxi People's Hospital), Aiping Zhang(Yangzhou University), Xia Peng(Shanghai Traditional Chinese Medicine Hospital), Luxi Song(Shanghai Jiao Tong University), Ling Shi(Shanghai University of Traditional Chinese Medicine)
Cited by 2
Related Papers
Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
|International Journal of Biological Sciences|2022|350
The 2.5 Å Crystal Structure of the SIRT1 Catalytic Domain Bound to Nicotinamide Adenine Dinucleotide (NAD<sup>+</sup>) and an Indole (EX527 Analogue) Reveals a Novel Mechanism of Histone Deacetylase Inhibition
|Journal of Medicinal Chemistry|2013|218
A Multicenter Application and Evaluation of the Oxford Classification of IgA Nephropathy in Adult Chinese Patients
|American Journal of Kidney Diseases|2012|157
Quantitative Proteomic Analyses of Human Cytomegalovirus-Induced Restructuring of Endoplasmic Reticulum-Mitochondrial Contacts at Late Times of Infection
|Molecular & Cellular Proteomics|2011|120